Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 6/20 | 0.39 |
| ▸ | PGK2 | P07205 | 6/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 2/20 | 0.31 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.31 |
| ▸ | ACP3 | P15309 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL578308 | 0.77 | CES2 (0.44) | PGK1PGK2CA2CA4CA5A | |
| SCHEMBL4148579 | 0.75 | CA2 (0.39) | PGK1PGK2CA2CA4CA5A | |
| SCHEMBL28875411 | 0.73 | PGK1 (0.50) | PGK1PGK2CA2CA4CA5A | |
| SCHEMBL25825774 | 0.73 | HDAC1 (0.47) | PGK1PGK2CA2CA4CA5A | |
| Water SCHEMBL28675682 | 0.70 | PGK1 (0.47) | PGK1PGK2CA2CA4CA5A | |
| SCHEMBL20379784 | 0.69 | CA2 (0.53) | PGK1PGK2CA2CA4CA5A | |
| SCHEMBL10072928 | 0.69 | CES2 (0.42) | PGK1PGK2CA2CA4CA5A | |
| SCHEMBL20379768 | 0.69 | CA2 (0.42) | PGK1PGK2CA2CA4CA5A | |
| SCHEMBL15565972 | 0.68 | CES2 (0.43) | PGK1PGK2CA2CA4CA5A | |
| SCHEMBL28460682 | 0.68 | CES2 (0.41) | DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | NATIONAL SCIENCE FOUNDATION | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | EFNA1, PHOSPHO1, EPHA6 | PGK1 546/4885PGK2 418/4885CA2 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.